By Tom Polansek and Greg Roumeliotis
(Reuters) - "There is nothing there."
Monsanto Co President Brett Begemann uttered those words last week to a small group of investors and a Reuters reporter when asked how the world's largest seed company he helps lead might fit with German drugs and crop chemicals group Bayer AG.
Those four words, said on the sidelines of a New York conference, set off a series of events leading to the disclosure of Bayer's confidential, $62 billion bid for Monsanto, the largest all-cash corporate takeover offer on record.
Bayer had sent a confidential acquisition proposal to Monsanto on May 10. Media reports surfaced two days later that Bayer was considering a bid.
Initially, neither company would comment on whether any talks were taking place - a common practice for many corporations that prefer to negotiate deals in private and only tell Wall Street if they manage to come to terms.
But Begemann appeared to go a step further than simply declining to comment at the May 18 conference. Monsanto's securities lawyer was concerned that his reply could be interpreted as a denial that any talks were going on, according to a person with knowledge of the situation.
The U.S. Securities and Exchange Commission has strict disclosure rules to protect investors from being misled by companies. To avoid triggering SEC scrutiny, according to the source, Monsanto issued a statement a few hours after Begemann's comment to acknowledge that Bayer had approached the company about a possible takeover.
Bayer soon followed with its own statement. The negotiations have since been subject to intense investor scrutiny that has weighed on Bayer's deliberations over how much it can pay, according to sources with knowledge of the talks.
The SEC declined to comment on whether it is looking into Begemann's remark.
Monsanto and Bayer also declined to comment, and Monsanto did not make Begemann available for comment. His remark was characterized by sources close to Monsanto as an "honest mistake."
Begemann came "close to a violation but probably not enough" for the SEC to bring a case, because his answer was open to interpretation, said Peter Henning, a law professor at Wayne State University in Michigan.
Begemann's statement could be interpreted to mean that Monsanto and Bayer had not come to a definitive agreement, Henning added.
CHARM OFFENSIVE
Bayer shares, which fell modestly after the initial media reports, dropped as much as 10 percent the day after the company confirmed the takeover approach, as investors fretted over the impact of such an acquisition on its strategy and balance sheet. Some of Bayer shareholders spoke out against doing a deal.